Skip to main content
. 2012 Aug 29;7:57. doi: 10.1186/1750-1172-7-57

Table 3.

Specific entities found in at least 5 patients and age at onset of disease

  Mean Min Max Main (yrs)
JIA
10.8
1
29
<17
APMPPE
20.2
17
27
17-40
Reactive arthritis
34.7
7
66
>17
SLE
30.7
13
53
36-60
Toxoplamosis
29.2
1
79
17-40
Crohn´s disease
34.7
18
64
17-40
Reiter´s disease
35.5
13
64
17-35
Ulcerative colitis
43.4
24
49
17-60
HCF
32.4
12
70
<40
Behcet´s disease
31.1
15
55
<40
Ocular toxocarosis
47.2
11
71
>17
HLA-B27 only eye
37.8
9
82
17-60
Unclassified cases
39.5
2
87
17-60
Psoriatric arthritis
39.8
23
49
36-60
Ancyl. spondylitis
39.5
17
75
17-60
MFC
38.6
16
77
17-60
MS
35.9
14
77
17-40
Sarcoidosis
40.1
5
78
17-60
Serpiginous
45.3
15
76
>36
ARN
43.9
7
62
1 > 17
Ocular herpes
47.8
2
88
>36
Systemic infections
47.5
3
80
17-60
VKH
42.6
30
78
>30
Birdshot
51.4
32
75
36-60
MASQ 55.2 10 80 >36

For each classification, mean age of onset of disease (mean), minimum age at onset of disease (min), maximum age at onset of disease (max) and the main age group where this specific entity is found (main).

JIA: juvenile idiopathic arthritis; APMPPE: acute posterior multifocal placoid pigment epitheliopathy; SLE: systemic lupus erythematosus; HCF: Fuchs’ heterochromic cyclitis; MFC: multifocal choroiditis; MS: multiple sclerosis; ARN: acute retinal necrosis; VKH: Vogt-Koyanagi-Harada disease; MASQ: masquerade syndromes.

HHS Vulnerability Disclosure